Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Tenth Record-Breaking Year in a Row for ZEISS
2019-12-11 20:59
GemVax announced phase II results of GV1001 for Alzheimer's disease treatment at CTAD 2019
2019-12-11 18:40
Xinhua Silk Road: E. China Nanjing Jiangbei New Area aims to develop life and health industry
2019-12-11 16:52
West China Hospital to build new hospital in Chengdu Tianfu New Area
2019-12-11 13:47
CStone announces enrollment target reached in the global Phase III VOYAGER trial of avapritinib in Chinese patients with third-line GIST
2019-12-11 11:00
AGC Biologics Expands Plasmid DNA Offering
2019-12-11 09:06
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma
2019-12-11 08:41
Ascentage Pharma Releases Updated Data of its Novel BCR-ABL Inhibitor, HQP1351, in an Oral Presentation Nominated for "Best of ASH"
2019-12-11 08:00
Vision Impact Institute: New Reports on State of Vision Will Renew Global Focus on the Societal Impact of Poor Vision
2019-12-11 03:42
Conversa Honored by Frost & Sullivan for its Clinically Intelligent Connectivity Platform that Improves Care, Enhances Patient and Provider Experience
2019-12-10 22:00
PointClickCare Integrated Care Coordination Platform Applauded by Frost & Sullivan for Bridging the Communication Gap between Acute and Post-acute Healthcare Providers
2019-12-10 22:00
Breakthrough in Medical Electronics - A Novel Mixed & Augmented Reality Smart Glasses Surgical Navigation Solution
2019-12-10 16:34
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at the 2019 ASH Annual Meeting
2019-12-10 16:00
CStone's anti-PD-L1 antibody demonstrates promising antitumor activity with a complete response rate of 33.3% and a good safety profile in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma
2019-12-10 11:38
Farrer Park Hospital Implements Non-Invasive Treatment for Prostate Cancer Patients in Singapore
2019-12-10 08:15
Townsville Hospital Treats First Australian Patient With Elekta Unity MR-Linac, a Transformative Approach to Precision Radiation Therapy
2019-12-10 08:13
TechMah Medical & LimaCorporate Receive First 510k Approval for Smart SPACE Digital Technology
2019-12-10 02:08
Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies
2019-12-09 22:00
Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours
2019-12-09 21:01
BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors
2019-12-09 21:00
1
854
855
856
857
858
1624